Form D · Other Health Care
Presage Biosciences, Inc.
Seattle, WA · CIK 0001485311
Offering snapshot reported Mar 12, 2013 · SEC filing
- Reported sold
- $8M Offering amount: $15.8M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 1, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 12, 2013 | Initial | $8,000,000 | No comparison | 1 | SEC filing |
| Aug 4, 2011 | Initial | $1,566,295 | No comparison | 20 | SEC filing |
| Jun 18, 2010 | Amendment | $3,818,874 | $667,500vs Mar 22, 2010 | 51 | SEC filing |
| Mar 22, 2010 | Initial | $3,151,374 | No comparison | 45 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-193178
Source: Form D, filed Mar 12, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nathan Caffo | Executive |
| Caitlin Cameron | Director, Executive |
| Thane Kreiner | Director, Executive |
| Scott K. Murano | Executive |
| Ken Nussbacher | Director |
| James M. Olson | Director |
| George J. Todara | Director |
| George J. Todaro | Director |
| James C. Towne | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
530 Fairview Avenue, N. Suite 1000
Seattle, WA, 98109
Seattle, WA, 98109